We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
- Authors
Saltz, Leonard B; Clarke, Stephen; Díaz-Rubio, Eduardo; Scheithauer, Werner; Figer, Arie; Wong, Ralph; Koski, Sheryl; Lichinitser, Mikhail; Yang, Tsai-Shen; Rivera, Fernando; Couture, Felix; Sirzén, Florin; Cassidy, Jim
- Abstract
To evaluate the efficacy and safety of bevacizumab when added to first-line oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic acid plus oxaliplatin [FOLFOX-4]) in patients with metastatic colorectal cancer (MCRC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 12, p2013
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.14.9930